The Future of Pharmacometrics with Dr. Nathan Teuscher

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants.Chapters00:00 Episode Preview00:55 Introduction to BioTalk Unzipped02:06 Charity Spotlight: Light of the World04:51 Nathan Teuscher's Career Journey07:34 Differentiating AI Types in Life Science12:41 Challenges with Large Language Models15:39 Rethinking Reporting in Pharma17:56 The Future of AI and Analytics in Pharma?18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies23:05 Leveraging Data, AI, and APIs in 3 Dimensions26:22 NEW NEWS! - Gene Editing Breakthroughs in MedicineHow to reach us:Light the World Charity - Church of Jesus Christ Latter Day Saintshttps://www.churchofjesuschrist.org/comeuntochrist/light-the-world Nathan Teuscherhttps://www.linkedin.com/in/nathanteuscher/ Aplos Analytics - https://aplosanalytics.com/ Nathan Teuscher’s Podcast: Clinical Pharmacology Podcasthttps://teuschersolutions.com/ Collaboration with BioTalk Unzipped (Ep. 40)https://podcasts.apple.com/us/podcast/collaboration-with-biotalk-unzipped-ep-40/id1695617234?i=1000682122951 Dr. Chad Briscoehttps://www.linkedin.com/in/chadbriscoe/ Celerion - https://www.celerion.com/  Gregory Austinhttps://www.linkedin.com/in/gregoryaustin1/ ECI - https://eci-rx.com / Sound Bites"We don't need to write reports anymore."TakeawaysNathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics.Light the World charity offers unique giving machines for donations.AI can automate repetitive tasks in drug development, freeing up human capital for innovation.There are two types of AI: large language models and automated data analysis.Large language models can be unreliable in scientific contexts.Pharmaceutical companies spend significant resources on report writing, which may not add value.Small companies can leverage APIs to access standardized calculations and data analysis.The pharmaceutical industry is often insular, limiting the potential of AI.AI could potentially eliminate the need for extensive written reports in drug development.Collaboration and data sharing are crucial for advancing AI in the pharmaceutical industry. Leveraging data effectively requires combining various data sets and tools.The evolution of AI tools is crucial for navigating new technologies.Gene editing represents a significant breakthrough in organ transplantation.New News Story: A woman in the US is the third person to receive a gene-edited pig kidneyhttps://www.technologyreview.com/2024/12/17/1108905/a-woman-in-the-us-is-the-third-person-to-receive-a-gene-edited-pig-kidney/Image CreditsPig Kidney, https://ny1.com/nyc/all-boroughs/news/2023/08/16/pig-kidney-works-in-a-donated-body-for-over-a-month--a-step-toward-animal-human-transplants KeywordsBioTalk, pharmacology, AI in pharma, drug development, pharmacometrics, software development, clinical research, Light the World, charity, data analysis, AI tools, gene editing, kidney transplant, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare